JOYZYME GROUP (08622) announced annual performance, with a net loss attributable to shareholders of 5.06 million yuan, an increase of 20.39% year-on-year.
Yueyue Group (08622) announced its annual performance for the year ended December 31, 2025. The Group achieved a revenue of 28.282 million yuan, a year-on-year increase of 11.53%; the company's net loss attributable to owners expanded to 5.006 million yuan, a year-on-year increase of 20.39%; basic loss per share was 1 cent.
JOYZYME GROUP (08622) released its annual performance for the year ending on December 31, 2025. The group achieved a revenue of 28.282 million RMB during the period, an increase of 11.53% year-on-year. The company's attributable loss was 5.006 million RMB, an increase of 20.39% year-on-year. Basic loss per share was 1 cent.
Related Articles
INSILICO (03696) reached global pipeline authorization and AI drug development cooperation with Roche.
JIANGSU EXPRESS (00177) has announced its performance for 2025, with a net profit attributable to shareholders of approximately RMB 4.594 billion, representing a year-on-year decrease of about 7.13%.
New Stock News | Aqara International Ltd. Submits Application to Hong Kong Stock Exchange
INSILICO (03696) reached global pipeline authorization and AI drug development cooperation with Roche.
JIANGSU EXPRESS (00177) has announced its performance for 2025, with a net profit attributable to shareholders of approximately RMB 4.594 billion, representing a year-on-year decrease of about 7.13%.
New Stock News | Aqara International Ltd. Submits Application to Hong Kong Stock Exchange
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
